[Use of intravenous immunoglobulin in neurological disorders].
The use of intravenous immunglobulin in the treatment of Guillain-Barré-Syndrome, chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathies is well established. Other conditions, such as dysglobulinemic neuropathy, myasthenia gravis, multiple sclerosis and inclusion body myositis may also benefit from the administration of intravenous immunoglobulins.
Steck
Andreas J
AJ
Service de neurologie, Hôpital universitaire de Bâle, 4031 Bâle. asteck@uhbs.ch
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors